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1. Introduction 
Upon binding to their receptors, growth factors trigger intracellular signaling cascades. These 
cascades are propagated and modulated by many subsequent phosphorylation/ 
dephosphorylation events, which ultimately influence the cellular response. BDNF, a major 
growth factor of the central nervous system, is a member of the family of neurotrophins, which 
also comprises nerve growth factor (NGF) and neurotrophins (NT) 3 and 4. Neurotrophins bind 
to their cognate Trk receptor tyrosine kinases TrkA, B or C, to initiate downstream signaling 
events (Figure 1) (1, 2). During development, neurotrophins act as target-derived growth factors, 
which are essential for the survival of selective populations of neurons, especially within the 
peripheral nervous system (3). However, neurotrophin signaling extends well beyond effects on 
neuronal survival during development, and also plays important roles in higher order function 
in the adult, such as behavior, learning and memory. This is best characterized for BDNF- TrkB 
signaling. Mature BDNF facilitates long-term potentiation and dendritic spine formation in the 
hippocampus, a process that has been implicated in learning and memory (4). Animals with 
lower levels of BDNF or its receptor TrkB, as well as mice harboring a common polymorphism in 
the bdnf gene leading to decreased BDNF secretion, give rise to eating disorders and an increase 
in anxiety-related behaviour (5). Moreover, decreases in BDNF have been correlated with 
depression while increases in BDNF seem to have an antidepressant effect, and conversely, 
commonly prescribed anti-depressants raise BDNF levels (5, 6). 
In this chapter, we will describe in detail examples of feedback and feed-forward loops 
downstream of BDNF-TrkB signaling, which transmit and adjust the signal, and therefore 
determine the ultimate physiological outcome. These cascades comprise multiple protein 
phosphorylation and dephosphorylation events to modulate both the duration and 
localization of the signal, as well as the downstream targets affected. These processes help 
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shed light on how a single, well conserved ligand-receptor pair can have such diverse effects 
on cellular physiology as described above for BDNF-TrkB. 
 
The neurotrophin family consists of four closely related proteins encoded by four different genes that include NGF (nerve 
growth factor), BDNF (brain-derived neurotrophic factor), NT-3 (neurotrophin-3) and NT-4 (neurotrophin-4). Neurotrophins 
act as homodimeric ligands for the Trk (tropomyosin-related kinase) receptors. Three Trk receptors encoded by independent 
genes afford selectivity among neurotrophins with NGF and NT-3 binding to TrkA, BDNF and NT-4 binding to TrkB and 
NT-3 binding to TrkC. All Trk receptors are composed of extracellular leucine-rich repeats, cysteine-rich domains and a 
single immunoglobulin C2 domain that ensure proper conformation of the ligand-binding pocket. Neurotrophin binding 
promotes homodimerization of Trk receptors, which in turn initiates intracellular phosphorylation cascades. The 
intracellular tyrosine kinase domain common to all Trk receptors is necessary for neurotrophin signaling as it allows 
transphosphorylation of several key tyrosine residues of the Trk receptor dimer at the origin of pleiotropic neurotrophic 
function. Several splice isoforms of the Trk receptors encode for a truncated protein that lack large portions of the 
intracellular domain. The TrkB.T1 and TrkB.T2 isoforms lack the prototypical tyrosine kinase domain. These isoforms are 
abundant in the adult brain and notably in glial cells. Nevertheless, glial cells respond to neurotrophin by eliciting distinct 
intracellular events. For instance, BDNF signaling mediated by the glial truncated TrkB.T1 isoform elevate intracellular 
calcium and associated phosphorylation waves mediated by calcium-sensing proteins kinases like CaMK2. 
Figure 1. Neurotrophins and Trk neurotrophin receptor family of proteins. 
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2. Immediate changes in protein phosphorylation  
downstream of BDNF/ TrkB 
Activation of TrkB upon BDNF binding leads to receptor dimerization and 
phosphorylation, thereby creating docking sites for effector proteins that initiate the 
activation of intracellular signaling pathways (7). The phosphorylated tyrosine residues 
Y516 and Y817 in human TrkB receptor serve as the main docking sites to initiate 
downstream signaling pathways, such as Src homology 2 containing protein (Shc), Akt, 
mitogen-activated protein kinase (MAPK)/ extracellular signal-regulated kinase (Erk) 1/2 
and phospholipase C (PLC) γ (Figure 2) (1, 8). This in turn leads to the activation of various 
pathways involved in cellular functions that range from initiation of gene transcription and 
protein synthesis to decisions involved in cell growth and survival. The residues Y702, 
Y706 and Y707, located within the tyrosine kinase domain, can also recruit adaptor 
proteins when phosphorylated, including Grb2 and SH2B. At the same time as inducing 
multiple protein tyrosine, serine and threonine phosphorylation events in diverse proteins, 
BDNF stimulation may cause a reduction in the phosphorylation of other proteins, such as 
focal adhesion kinase (9), thereby reducing their activity. In the following paragraph, we 
will discuss in more detail multiple ways of neurotrophin-dependent activation of Erk1/2 
signaling pathways. 
3. Multiple cascades leading to BDNF-dependent Erk1/2 activation 
Three major pathways mediate activation of Erk1/2 downstream of BDNF: PLCγ/ PKC 
signaling following phosphorylation of Y817 site, or Shc-Grb2 signaling through Ras or 
Rap1 (Figure 3) (1).  
Phosphorylation of hTrkB (human TrkB) at the most C-terminal tyrosine, Y817, leads to the 
recruitment and activation of PLCγ, which hydrolyses phosphatidylinositol(4, 
5)bisphosphate (PI(4,5)P2) into diacylglycerol (DAG) and inositol tris-phosphate (IP3). IP3 
subsequently leads to release of intracellular Ca2+, which in turn activates Ca2+-dependent 
enzymes such as Ca2+-calmodulin-regulated protein kinases (CaM kinases), as well as the 
phosphatase calcineurin. Additionally, the release of Ca2+ and the production of DAG 
activate protein kinase C (PKC), which stimulates Erk1/2 signaling via activation of Raf and 
the mitogen activated protein kinase kinase MEK. 
Along another pathway leading to active Erk, phosphorylation of hTrkB at the tyrosine 
residue closest to the plasma membrane, Y516, creates an Shc binding site to initiate 
downstream transient or prolonged Erk1/2 signaling. Transient activation follows the 
recruitment of a complex of growth factor receptor bound protein 2 (Grb2) and the Ras 
activator son of sevenless (SOS), which in turn stimulates activation of Ras and 
downstream, the activation of the c-Raf/ MEK/ Erk1/2 cascade. Erk in turn 
phosphorylates SOS, leading to the dissociation of the Grb2/ SOS complex, which then 
no longer activates the Ras/ c-Raf/ MEK cascade, thus only leading to transient 
activation of Erk. 
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Upon binding to BDNF, a series of tyrosine phosphorylation events occur within TrkB cytoplasmic domain. These 
phospho-tyrosine residues form unique binding sites for intracellular adaptor proteins, Y516 and Y817 recruiting 
specifically Shc and PLCγ, respectively. The typical wave of second messengers involves, PLCγ, which raises 
intracellular calcium, the Ras-Erk and PI3-Kinase/Akt pathways.  The elevation of intracellular calcium allows the 
activation of CAMK (calmodulin kinases), which converges with the Erk pathway to activate transcription factors like 
CREB within the nucleus by phosphorylation on S133. Trancription factors like CREB transform transient BDNF 
signaling into durable signaling by changing the expression of many selective target genes.  
 
Figure 2. Proximal intracellular signaling of the TrkB receptor. 
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Prolonged Erk activation is also initiated at the Y516 site, but requires the adaptor protein 
ankyrin-rich membrane spanning protein (ARMS, also known as Kidins220), which recruits 
Grb2 and CrkL. This complex formation depends on tyrosine phosphorylation of ARMS at 
the residue Y1096. Binding to CrkL then activates the Rap exchange factor C3G and thus 
initiates prolonged Rap1/ Raf-dependent MEK/ Erk1/2 signaling. Accordingly, loss of ARMS 
impairs Rap1 activation and prolonged activation of Erk1/2, while early Erk1/2 activity is not 
affected (10). 
Ultimately, Erk1/2 signaling not only promotes local axonal growth via cytosolic signaling 
events, but activated Erk1/2 can also translocate to the nucleus to phosphorylate and 
activate transcription factors, such as CREB (cAMP response element-binding), leading to 
the initiation of transcriptional events and the expression of immediate early genes (IEGs), 
which can further modulate the response (11). 
4. The importance of signal duration 
In the mid 1990s, it became widely recognized that the actual signal duration will 
critically influence the ultimate cellular outcome (12). Because the MAPK pathway (e.g. 
Erk1/2, JNK, P38) is central for the activation of transcription factors, the expression of a 
large array of genes is sensitive to extracellular trophic factors, such as BDNF (13). One 
classical example that highlights the importance of the temporal control of signaling is the 
activation of Erk1/2 downstream of NGF versus EGF in pheochromocytoma (PC12) cells 
(14). NGF leads to sustained activation of Erk1/2 by inducing a positive feedback loop on 
to the upstream activator Raf, whereas EGF activates a negative feedback loop to Raf and 
thus leads to transient activation of Erk1/2. As a consequence, EGF promotes cell division, 
while NGF initiates differentiation. This is not specific to PC12 cells, as sustained Erk1/2 
activity also transforms fibroblasts and macrophages (15, 16). Indeed, under pathological 
conditions unrestricted activation of the Ras-Erk1/2 pathway through point mutations is 
one of the most frequently identified cellular defects leading to tumour formation and 
cancer (17). 
One explanation for a differential duration of Erk1/2 activation downstream of different 
growth factors may be the expression levels of their cognate receptors. Indeed, PC12 clones 
with low amounts of the NGF receptor TrkA fail to differentiate in response to NGF, while 
PC12 cells overexpressing EGF receptor can undergo differentiation in response to EGF (18). 
In line with this, tumour cells frequently upregulate growth factor receptors, leading to 
aberrant activation and transformation (19). 
In addition to activation through distinct cascades, both positive and negative feedback 
loops further influence the amplitude and duration of MAPK signals. For example, BDNF 
induces its own release, thus initiating further rounds of receptor-mediated signal 
activation (20). On the other hand, Erk1/2 phosphorylates SOS, which impairs SOS-Grb2 
complex formation and thus decreases further activation of Erk1/2 (21). Moreover, 
multiple phosphatases (PP1, PP2a and MKPs) inactivate ERKs, implying that the duration 
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and extent of ERK activation is controlled by the balanced activities of the upstream ERK 
kinases, MEKs, as well as MEK and ERK phosphatases (22-24). Modeling approaches 
showed that these multiple layers of feedback along the MAPK cascade can not only 
determine the strength and timing of the signal, but also induce robust and sustained 
signal oscillations, thereby ultimately allowing for a multitude of biological outcomes 
(25). 
5. Localizing the signal: Signal transduction cascades versus trafficking 
and intracellular localization of the ligand-receptor complex 
Receptor tyrosine kinases are activated by ligand binding at the cell surface. They are 
subsequently internalized into the endosomal pathway and either recycled back to the 
plasma membrane for further rounds of activation, or sorted to the lysosome for 
degradation. For a long time, the classical belief was that signal transduction terminates 
with receptor internalization. However, receptors are internalized very rapidly upon 
activation, thus leaving only a short time window to induce signal transduction. In the mid 
1990s the view changed and it became accepted that receptors continue to signal following 
internalization, from so-called signaling endosomes (26-28). Much work has since focused 
on endosomes as signaling platforms, and it is now well established that cascades such as 
the Erk1/2 or Akt pathways can be initiated from endosomal membranes. For example, the 
MEK1 scaffold, MEK partner 1 (MP1), recruits MEK1 and Erk1/2 to endosomal membranes, 
and knockdown of MP1 leads to lack of recruitment and a concomitant reduction in Erk1/2 
signaling (29).  
The essential role of signaling from endosomes in physiological processes such as 
polarization and migration is widely accepted. In addition, a large body of work has 
highlighted the importance of signaling endosomes in neurons, where signals at times have 
to traverse large distances. For example, intracellular trafficking of the signal-receptor 
complex from the synapse along the axon and to the cell body is essential for health and 
survival of neurons of the peripheral nervous system, which depend on target-derived 
growth factors (30, 31). Consequently, mutations in genes involved in this retrograde axonal 
transport process are frequently associated with neuropathies (32). 
Interestingly, two recent studies in cell lines questioned the view that intracellular 
trafficking of the activated ligand-receptor complex is critical for downstream cellular 
responses (33, 34). Following EGF stimulation, they demonstrated that the cascades 
eventually influencing transcriptional changes are already initiated at the plasma 
membrane, and within a short time after ligand binding. Consequently, interfering  
with subsequent ligand-receptor sorting had only minor effects on the overall 
transcriptional response. How these findings apply to different cell systems, for 
example in highly polarized cells such as neurons, remains to be seen. At least for 
peripheral neurons, it has been demonstrated that internalization of the NGF-TrkA 
complex at the distal axon is strictly required for activation of CREB, initiation of 
transcription, and survival (28). 
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6. Activation of an essential CREB co-activator through 
dephosphorylation 
Phosphorylation of CREB is an activation mark that is required but not sufficient to induce the 
expression of responsive-genes (35). The CREB co-activator, transducer of regulated CREB 
(TORC or CRTC) must be actively transported to the nucleus to allow CREB-dependent 
transcription of target genes (35). There are three members of the CRTC family (CRTC1/2/3) 
that are encoded by independent genes. Each isoform presents specific expression profile and 
binding to CREB-occupied genes, but redundancy was highlighted by loss-of-function 
experiments (36). For instance, CRTC1 null mice decrease BDNF expression in the prefrontal 
cortex and hippocampus down to 40 % of wildtype levels, suggesting additional mechanisms 
of regulation and/ or compensatory mechanisms (37). Knockdown of CRTC1, the major 
isoform in the limbic brain is sufficient to prevent BDNF-induced structural plasticity such as 
dendritic and axonal arborization, as well as physiological features like long-term potentiation 
that also depends on BDNF/TrkB signaling (38, 39). Because the transcriptional activity of 
CREB downstream of BDNF depends on CRTC1 and perhaps other CRTC isoforms, it is now 
interesting to describe how CRTC1 function is regulated.  
When phosphorylated, CRTC proteins reside in the cytoplasm of resting neurons via high 
affinity interactions with 14-3-3, a family of cytoplasmic scaffold proteins that help organize 
and sequester phosphorylated proteins in the cytoplasm. Upon neuronal activation, CRTC 
proteins become dephosphorylated notably at residues S171, S275 and S307, which unmask a 
nuclear localization sequence and permit the translocation of CRTC proteins into the nucleus 
(40). If at the same time CREB is phosphorylated, the formation a CREB-CRTC1-CBP protein 
complex can drive transcription at target genes (Figure 3). Such a mode of action raises 
questions about the coincidence detection mechanisms that allow the convergence of CREB 
phosphorylation and CRTC dephosphorylation. Calcineurin, a calcium sensing phosphatase, 
directly dephosphorylates CRTC proteins. BDNF signaling induces robust and sustained 
phosphorylation of CREB, but cannot elicit nuclear translocation of CRTC1 (38). In similar 
experiments conducted in hypothalamic neurons, where CRTC2 is the major isoform 
expressed, BDNF signaling did not elicit CRTC2 translocation to the nucleus, while cAMP-
elevating drugs or drugs that elevate intracellular calcium did (41). Although BDNF/TrkB 
signaling has been previously shown to elevate cAMP and calcium levels in neurons (1, 42), it 
is believed to occur and remain local, such as neurite terminals (20). However, it is clear that 
elevation of intracellular cAMP or calcium facilitate the functional and morphological synaptic 
responses to BDNF signaling (43, 44). Elevation of intracellular calcium activates calcineurin 
whereas cAMP activates PKA, which in turn phosphorylates and deactivates the upstream 
CRTC kinase, salt-inducible kinase (SIK). Only such coordinated signaling guarantees efficient 
translocation of CRTC proteins to the nucleus (Figure 3). So, what neuronal mechanisms 
mediate calcineurin-dependent dephosphorylation of CRTC protein? Neuronal activity via 
calcium-permeable glutamate ion channels not only phosphorylates CREB, but also triggers 
the calcineurin-dependent dephosphorylation of CRTC1 in cortical neurons and of CRTC2 in 
hypothalamic neurons that is necessary to activate CREB-mediated transcription (38, 41).  
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Figure 3. Subcellular compartmentalization of CRTC proteins regulates their function as necessary 
CREB-cofactors. CRTC proteins are constitutively phosphorylated in many cell types including neurons. 
Consequently, they reside in the cytoplasm via sequestration by the 14-3-3 family of proteins. When 
actively dephosphorylated by the calcium-sensing phosphatase calcineurin, a nuclear localization 
sequence is unmasked and CRTC translocates to the nucleus. Efficient translocation of CRTC protein to 
the nucleus is also governed by concomitant inactivation of the CRTC upstream kinases like SIK (Salt-
inducible kinase) via its phoshorylation by the protein kinase A. Once in the nucleus, CRTC proteins 
form a multi-complex with the phosphorylated form of CREB, thus, acting as a permissive signal for 
robust and specific genomic signaling response.  
7. Wait a minute: Immediate-early gene expression following  
BDNF stimulation 
Following the immediate phosphorylation and dephosphorylation events, BDNF signaling 
eventually results in a nuclear response and immediate-early gene (IEG) expression. This 
process starts within minutes, and the first translated proteins are detectable within 30 min 
following the initial stimulation. Many IEGs are themselves transcription factors, such as fos, 
which will set off a series of transcription/ translation waves to adjust the cellular 
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transcriptome and proteome. Other IEGs directly modulate cellular shape and 
responsiveness. The probably best-characterized BDNF-sensitive IEG is Arc (Arg3.1), a 
modulator of actin depolymerizing factor (ADF)/ cofilin activity and regulator of AMPA 
receptor trafficking (45). Local translation of Arc plays an essential role in the consolidation of 
long-term potentiation, which equates to an increase in synaptic transmission in response to 
neuronal activity. In addition, BDNF initiates its own synthesis and release, thereby 
strengthening and prolonging its own signal and starting a positive feedback loop. Other 
IEGs induced by Erk1/2 signaling are phosphatases, which provide a negative feedback loop. 
For example, we recently reported that BDNF-TrkB signaling induces the expression of the 
dual-specificity phosphatase MKP-1 (MAP kinase phosphatase 1, also known as DUSP1) (46). 
MKPs comprise a family if phosphatases that recognize and dephosphorylate both the 
threonine (T) and tyrosine (Y) within a TxY motif in the catalytic core that is conserved 
among the family of MAPKs (24). Below, the role of MKP-1 expression in modulating MAPK 
signaling, and its ultimate cellular consequences, will be discussed in greater detail. 
8. MKP-1 molds the MAPK signal and neuronal morphology 
Basal MKP-1 protein levels within the cell are very low, but its expression is induced 
following Erk1/2 activation by growth factors in a variety of cell types (47). Generally, MKPs 
have a preference for specific members of the MAPK family, and the favored substrates for 
MKP-1 are JNK, p38 and Erk1/2. Therefore, MKP-1 can terminate the signal that initially 
induced its expression (24). This form of feedback inhibition is a common theme in many 
signal transduction events, such as discussed above for Erk1/2 signaling. After induction, 
MKP-1 is rapidly degraded by the proteasome within one hour post stimulation. But BDNF 
signaling prolongs MKP-1 protein stability by several hours (46). Erk1/2-dependent 
phosphorylation of carboxy-terminal serine residues can modulate the half-life of MKP-1 
protein. One study proposed that phosphorylation of serines 296 and 323 is required for 
recognition of MKP-1 by the ubiquitin ligase, thereby promoting degradation (48), while 
another study suggested that phosphorylation at serines 359 and 364 interferes with 
ubiquitination and thus prevents degradation (49). Serial mutagenesis of such signature 
motifs helped crack MKP-1 phosphorylation code (Figure 4). Only the mutations of all four 
phospho-sites alter significantly MKP-1 protein half-life whereas mutations of individual 
phospho-sites or motifs (S296/S323 and S359/S364) are mainly ineffective. Notably, alanine 
mutations in place of serines 359 and 364 as well as phospho-mimicking glutamate 
mutations in place of serines 296 and 323 in a single quadruple mutant diminish MKP-1 
protein stability despite BDNF signaling. Therefore, BDNF signaling not only induces mkp-1 
expression but also prolongs MKP-1 protein half-life as a result of phosphorylation/ 
dephosphorylation of MKP-1 C-terminal signature motifs (Figure 4) (46). If the kinase 
involved in MKP-1 phosphorylation at serine 359 in neurons is Erk1/2, the identity of the 
phosphatases for serines 296 and 323 are presently unknown.  
Within the immune system, MKP-1 is largely nuclear. One of its best-described functions is 
terminating cytokine production and therefore the immune response by inactivating p38 
and p38-mediated transcription following an immune challenge. Indeed, mice lacking  
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Figure 4. Mkp-1 is a BDNF and CREB sensitive gene. Among the many genes regulated by CREB, mkp-1 
is an immediate early gene that can be expressed within minutes of BDNF stimulation. With low basal 
expression in resting neurons, the induction of the mkp-1 gene product represents a mechanism of 
activation necessarily delayed in time from the initial BDNF signaling cascade. It is thought that MKP-1 
protein serves to terminate the MAPK signaling via a negative feedback loop mechanism, since MKP-1 
is a deactivating MAPK phosphatase. To support this view, the protein turnover of MKP-1 is extremely 
rapid (< 1 hour) allowing the rapid reinstatement of basal MAPK signaling homeostasis. Of note, 
phosphorylation of MKP-1 by Erk is sufficient to stabilize the protein. This serves to maintain MKP-1 
function where needed in the cell whereas other signaling compartments lacking Erk signaling are 
preserved. So, MKP-1 induction and stabilization offers a sophisticated mode of regulation for MAPK 
signaling in time and space. 
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MKP-1 die due to cytokine overproduction after activation of the immune system (50). In 
neurons, MKP-1 localises to the cytosol. Here, it inactivates JNK, which is constitutively active 
within axons of neurons of the central nervous system (51). Prolonged MKP-1 expression thus 
leads to decreased phosphorylation of JNK substrates. Among the neuronal JNK substrates are 
many cytoskeleton-associated proteins, such as neurofilaments, tau and stathmins (46). The 
role of neurofilament phosphorylation is still debated, but has been suggested to influence its 
axonal transport rate and therefore subcellular localization. Tau has an exceptionally complex 
phosphorylation signature, and its over 30 phosphorylation sites are affected by many 
different kinases and phosphatases (52). Under physiological conditions, tau binds to and 
stabilizes existing microtubules and promotes microtubule growth, but pathological 
hyperphosphorylation leads to self-assembly of tau, which results both in tau tangles and also 
in microtubule detabilization. In contrast, the role of phosphorylation on stathmin activity is 
much better elucidated. Stathmins have four phosphorylation sites, all of them serine residues 
(53). When phosphorylated at these residues, stathmins are inactive, and dephosphorylation 
therefore equates to activation. Active stathmins sequester free tubulin dimers, the building 
blocks for microtubules, and therefore passively decrease microtubule growth (53). This results 
in an increase in microtubule dynamics or a decrease in microtubule stability.  
Spatio-temporal control of MKP-1 expression is critical to increase dynamic microtubules, a 
prerequisite for the remodeling of the cytoskeleton that manifests in the forms of branching or 
pruning of axonal collateral arbors. For instance, transient expression of MKP-1 permits 
branching of axons (46). On the other hand, disruption of such spatio-temporal expression of 
MKP-1, in the forms of ectopic expression or sustained protein half-life over prolonged periods 
of time impedes axonal growth or prunes axons, depending on the developmental window.  
9. From behavior to MKP-1 and back 
Arborization of axons is critical to adjust neural network wiring to environmental needs. 
Behavioral experience evokes multiple signaling pathways that converge to cytoskeletal 
remodeling via both slow genomic and rapid non-genomic mechanisms. Protein 
phosphorylation is instrumental in the signaling toolbox that controls both of these programs. 
The balance of phosphorylation and dephosphorylation of the molecular components of the 
cytoskeletal machine dictates, in part, its continuous plasticity (54). By challenging this 
equilibrium at defined subcellular locations, timely, BDNF signaling instructs the position of 
branching points that mold the topographic maps of innervation. The manifold aspects of 
phosphorylation on BDNF signaling in this process can be illustrated by the molecular 
mechanisms that regulate the expression, localization and degradation of MKP-1, the dual 
specificity MAPK phosphatase. Induction of MKP-1 requires both a linear phosphorylation 
cascade through the MAPK-ERK1/2-CREB pathway and a feed-forward dephosphorylation 
switch via the calcineurin-CRTC1/2 pathway (Figure 5). Failure of either signaling branches 
prevents mkp-1 expression, which impinge on activity-dependent remodeling of the 
cytoskeleton. Baseline mkp-1 mRNA expression is limited in the brain of naturally behaving 
songbirds and rodents (55, 56).  But hearing song, seeing visual stimuli, or performing motor 
behavior robustly increases mkp-1 transcripts respectively, in auditory, visual, and 
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somatosensory neurons (56-58). Therefore, expression of mkp-1 is driven by neural activity in 
the primary sensory areas of the brain. What may result from the deregulation of MKP-1 
expression during higher order behaviors? When ectopically expressed in humans and animal 
models, MKP-1 triggers depressive behavior (55). In contrast, genetic disruption of mkp-1 
protects from stress in an animal model (55). Therefore, too little MKP-1 may prevent activity-
dependent remodeling of axons and dendrites that is necessary for behavioral adaptation, 
learning and memory. In contrast, too much MKP-1, as observed in depression and stress, may 
destabilize cytoskeletal architecture that impinges on the maintenance of functional neural 
networks. How titration of MKP-1 levels affects structural characteristics such as dendritic 
spines, physiological features like long-term potentiation and cognitive performance like 
learning and memory is unknown. Future investigations will shed light into these possibilities. 
 
Figure 5. BDNF signaling from the plasma membrane to the nucleus. Activation of TrkB by BDNF 
rapidly elicits numerous waves of protein phosphorylation that converge to the nucleus to trigger a 
genomic response. Coincidence detectors like CRTC proteins may determine the nature of the genomic 
response based on the cellular context. In effect, phosphorylation of CREB by BDNF signaling is 
required but not sufficient to elicit a transcriptional response. Neuronal activity and excitatory 
neurotransmitter, glutamate signaling converge to CREB activation via the dephosphorylation and 
nuclear translocation of the CREB-coactivors, CRTC. Among the regulated genes, MKP-1 is a MAPK 
phosphatase that terminates upstream BDNF-induced signaling in a delayed fashion. But MKP-1 serves 
also to deactivate JNK, which is constitutively activated in the axon. In consequence, many of the JNK 
substrates that serve cytoskeletal attributes are dephosphorylated. Numerous cytoskeletal-binding 
proteins that are substrates of JNK are either activated or deactivated upon phosphorylation. Spatio-
temporal phosphorylation and dephosphorylation of these proteins helps maintain the integrity of the 
cytoskeletal architecture of the axon, as much as its remodeling capacity.  
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10. Conclusion  
We have described how multiple steps of phosphorylation and dephosphorylation along the 
signaling pathways initiated by the neurotrophin BDNF determine its function via its receptor 
TrkB. These phosphorylation and dephosphorylation loops serve to efficiently activate in time 
and space the downstream components of BDNF signaling either proximal to the plasma 
membrane or distal in the nucleus. Concurrent activation of a kinase and deactivation of the 
substrate’s phosphatase is a common, but not exclusive mechanism to ensure both the 
robustness and fidelity of the output signal. Indeed, phosphorylated or dephosphorylated 
residues may serve to accelerate or delay the target protein’s turnover as exemplified by MKP-
1. Where BDNF signaling is not capable of initiating its entire signaling machinery such as the 
dephosphorylation of CRTC proteins, it relies on converging signaling pathways. Coincidence 
detectors, like CRTC proteins may serve to ‘gate’ neurotrophin signaling and filter the 
physiological output consequences as a function of the cellular context.  
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